TEST BANK FOR RAUS
RESPIRATORY CARE
PHARMACOLOGY 9TH
EDITION BY GARDENHIRE
,Chapter 01: Introduction to Respiratory Care Pharmacology
Gardenhire: Rau’s Respiratory Care Pharmacology, 9th Edition
MULTIPLE CHOICE
1. The listing of a drug and the amount of drug are found in which part of a prescription?
a. Superscription
b. Inscription
c. Subscription
d. Transcription (signature)
ANS: B
The superscription directs the pharmacist to take the drug listed and prepare the medication; the inscription lists
the name and quantity of the drug being prescribed; the subscription provides directions to the pharmacist for
preparing the medication; and the transcription, or signature, is the information the pharmacist writes on the
label as instructions to the patient.
REF: p. 7
2. If generic substitution is permitted on a prescription:
a. drug from only one manufacturer must be given.
b. drug formulation may be changed by the pharmacist.
c. any manufactured brand of the drug listed may be given.
d. drug strength may be changed by the pharmacist.
ANS: C
A generic substitution allows any brand of a drug to be given, but the pharmacist may not change a drug
formulation without specific permission from the prescribing physician. A physician can indicate to the
pharmacist that generic substitution is permitted in the filling of the prescription. In such a case, the pharmacist
may provide any manufacturer’s version of the prescribed drug, rather than a specific brand. However, the
pharmacist may not change the strength of a drug without specific permission from the prescribing physician.
REF: p. 8
3. The study of drugs, including their origin, properties, and interactions with living organisms, is known as
a. pharmacogenetics.
b. pharmacology.
c. therapeutics.
d. toxicology.
ANS: B
Pharmacogenetics is the study of the interrelationship of genetic differences and drug effects. Pharmacology is
the study of drugs (chemicals), including their origin, properties, and interactions with living organisms.
Therapeutics is the art of treating disease with drugs. Toxicology is the study of toxic substances and their
pharmacologic actions, including antidotes and poison control.
REF: p. 3
4. The brand name given to a drug by a particular manufacturer is known as the drug’s
a. chemical name.
b. generic name. c. official name. d. trade name.
ANS: D
The chemical name indicates the drug’s chemical structure. The generic name is assigned by the United States
Adopted Name Council and is usually based loosely on the drug’s chemical structure. The official name is the
,name given to the generic name once a drug becomes fully approved for general use and is admitted to the
United States Pharmacopeia–National Formulary. The trade name is the brand, or proprietary, name given by a
particular manufacturer. For example, the generic drug albuterol is currently marketed by Schering-Plough as
Proventil ® and by GlaxoSmithKline as Ventolin®.
REF: p. 5
5. To find official information about drugs (according to the FDA), you need to go to the
a. Physician’s Desk Reference (PDR).
b. Basic & Clinical Pharmacology.
c. United States Pharmacopeia–National Formulary (USP-NF).
d. Goodman & Gilman’s The Pharmacological Basis of Therapeutics.
ANS: C
Because the PDR is prepared by drug manufacturers themselves, it may be lacking in objectivity. Basic &
Clinical Pharmacology covers only general pharmacologic principles and drug classes. Goodman & Gilman’s
The Pharmacological Basis of Therapeutics covers only general pharmacologic principles and drug classes. The
USP-NF is a book of standards containing information about medications, dietary supplements, and medical
devices. The U.S. Food and Drug Administration (FDA) considers this book the official standard for drugs
marketed in the United States.
REF: p. 5
. 1
, 6. Drugs may be obtained from which of the following sources?
a. Plants
b. Animals
c. Minerals
d. Plants, animals, and minerals
ANS: D
Drugs may be obtained from plants (e.g., digitalis), animals (e.g., insulin), and minerals (e.g., magnesium
sulfate).
REF: p. 5
7. The branch of the U.S. government responsible for the process of approving drugs for clinical use is the
a. USAN Council.
b. FDA.
c. USP-NF.
d. PDR.
ANS: B
The United States Adopted Name (USAN) Council is responsible for assigning a generic name to a chemical
that appears to have therapeutic use. The U.S. Food and Drug Administration (FDA) is responsible for the
process of approving drugs for clinical use. The process by which a chemical moves from the status of a
promising potential drug to one fully approved by the FDA for general clinical use is, on average, long, costly,
and complex. Cost estimates vary, but in the 1980s it took an average of 13 to 15 years
from chemical synthesis to marketing approval by the FDA, with a cost of $350 million in the United States.
The USP-NF is a book
of standards for medications, dietary supplements, and medical devices. The PDR is a source of drug
information prepared by drug manufacturers.
REF: p. 4
8. An orphan drug is a drug that is
a. used for rare disease.
b. used for common disease.
c. inexpensive to produce.
d. not claimed by a drug manufacturer.
ANS: A
An orphan drug is a drug or biologic product for the diagnosis or treatment of a rare disease. Rare is defined as
a disease that affects less than 200,000 persons in the United States. Alternatively, a drug may be designated as
an orphan if used for a disease that affects more than 200,000 persons in the United States but for which there is
no reasonable expectation of recovering the cost of drug development. Orphan drugs are often quite expensive
to produce because they have a limited market in which to recoup the initial investment.
REF: p. 6 | p. 7
9. Which of the following health care practitioners are authorized to write a prescription in the United States?
1. Physicians
2. Chiropractors
3. Dentists
4. Osteopaths
5. Veterinarians
a. 1 only
b. 1, 2, and 3 only
RESPIRATORY CARE
PHARMACOLOGY 9TH
EDITION BY GARDENHIRE
,Chapter 01: Introduction to Respiratory Care Pharmacology
Gardenhire: Rau’s Respiratory Care Pharmacology, 9th Edition
MULTIPLE CHOICE
1. The listing of a drug and the amount of drug are found in which part of a prescription?
a. Superscription
b. Inscription
c. Subscription
d. Transcription (signature)
ANS: B
The superscription directs the pharmacist to take the drug listed and prepare the medication; the inscription lists
the name and quantity of the drug being prescribed; the subscription provides directions to the pharmacist for
preparing the medication; and the transcription, or signature, is the information the pharmacist writes on the
label as instructions to the patient.
REF: p. 7
2. If generic substitution is permitted on a prescription:
a. drug from only one manufacturer must be given.
b. drug formulation may be changed by the pharmacist.
c. any manufactured brand of the drug listed may be given.
d. drug strength may be changed by the pharmacist.
ANS: C
A generic substitution allows any brand of a drug to be given, but the pharmacist may not change a drug
formulation without specific permission from the prescribing physician. A physician can indicate to the
pharmacist that generic substitution is permitted in the filling of the prescription. In such a case, the pharmacist
may provide any manufacturer’s version of the prescribed drug, rather than a specific brand. However, the
pharmacist may not change the strength of a drug without specific permission from the prescribing physician.
REF: p. 8
3. The study of drugs, including their origin, properties, and interactions with living organisms, is known as
a. pharmacogenetics.
b. pharmacology.
c. therapeutics.
d. toxicology.
ANS: B
Pharmacogenetics is the study of the interrelationship of genetic differences and drug effects. Pharmacology is
the study of drugs (chemicals), including their origin, properties, and interactions with living organisms.
Therapeutics is the art of treating disease with drugs. Toxicology is the study of toxic substances and their
pharmacologic actions, including antidotes and poison control.
REF: p. 3
4. The brand name given to a drug by a particular manufacturer is known as the drug’s
a. chemical name.
b. generic name. c. official name. d. trade name.
ANS: D
The chemical name indicates the drug’s chemical structure. The generic name is assigned by the United States
Adopted Name Council and is usually based loosely on the drug’s chemical structure. The official name is the
,name given to the generic name once a drug becomes fully approved for general use and is admitted to the
United States Pharmacopeia–National Formulary. The trade name is the brand, or proprietary, name given by a
particular manufacturer. For example, the generic drug albuterol is currently marketed by Schering-Plough as
Proventil ® and by GlaxoSmithKline as Ventolin®.
REF: p. 5
5. To find official information about drugs (according to the FDA), you need to go to the
a. Physician’s Desk Reference (PDR).
b. Basic & Clinical Pharmacology.
c. United States Pharmacopeia–National Formulary (USP-NF).
d. Goodman & Gilman’s The Pharmacological Basis of Therapeutics.
ANS: C
Because the PDR is prepared by drug manufacturers themselves, it may be lacking in objectivity. Basic &
Clinical Pharmacology covers only general pharmacologic principles and drug classes. Goodman & Gilman’s
The Pharmacological Basis of Therapeutics covers only general pharmacologic principles and drug classes. The
USP-NF is a book of standards containing information about medications, dietary supplements, and medical
devices. The U.S. Food and Drug Administration (FDA) considers this book the official standard for drugs
marketed in the United States.
REF: p. 5
. 1
, 6. Drugs may be obtained from which of the following sources?
a. Plants
b. Animals
c. Minerals
d. Plants, animals, and minerals
ANS: D
Drugs may be obtained from plants (e.g., digitalis), animals (e.g., insulin), and minerals (e.g., magnesium
sulfate).
REF: p. 5
7. The branch of the U.S. government responsible for the process of approving drugs for clinical use is the
a. USAN Council.
b. FDA.
c. USP-NF.
d. PDR.
ANS: B
The United States Adopted Name (USAN) Council is responsible for assigning a generic name to a chemical
that appears to have therapeutic use. The U.S. Food and Drug Administration (FDA) is responsible for the
process of approving drugs for clinical use. The process by which a chemical moves from the status of a
promising potential drug to one fully approved by the FDA for general clinical use is, on average, long, costly,
and complex. Cost estimates vary, but in the 1980s it took an average of 13 to 15 years
from chemical synthesis to marketing approval by the FDA, with a cost of $350 million in the United States.
The USP-NF is a book
of standards for medications, dietary supplements, and medical devices. The PDR is a source of drug
information prepared by drug manufacturers.
REF: p. 4
8. An orphan drug is a drug that is
a. used for rare disease.
b. used for common disease.
c. inexpensive to produce.
d. not claimed by a drug manufacturer.
ANS: A
An orphan drug is a drug or biologic product for the diagnosis or treatment of a rare disease. Rare is defined as
a disease that affects less than 200,000 persons in the United States. Alternatively, a drug may be designated as
an orphan if used for a disease that affects more than 200,000 persons in the United States but for which there is
no reasonable expectation of recovering the cost of drug development. Orphan drugs are often quite expensive
to produce because they have a limited market in which to recoup the initial investment.
REF: p. 6 | p. 7
9. Which of the following health care practitioners are authorized to write a prescription in the United States?
1. Physicians
2. Chiropractors
3. Dentists
4. Osteopaths
5. Veterinarians
a. 1 only
b. 1, 2, and 3 only
